Topic Archives: Arena Pharmaceutical (ARNA)

Today we’ve got another ridiculous promise, made to sell you a subscription to a very expensive and nonrefundable newsletter — sound familiar? This time it’s Jim Pearce advertising Investing Daily’s Radical Wealth Aliance, which will run you $2,495 (“on sale” from $5,000) with no hope of a refund (they offer the “if you don’t like […]

[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. Enjoy!] It could be the premise of a tawdry unrated movie that teenage boys sneak glimpses of on Netflix when they’re home alone. […]

Stansberry & Associates’ Phase 1 Investor newsletter is teasing us about shares of a drug company: “On March 30, FDA results we’ve waited 2 years to receive could make you $195,600, overnight” — and they quote Porter Stansberry as saying that “This is the kind of situation that can change your life… where a $10,000 stake can allow you to literally quit work, forever.” Sounds nice, eh?

Comments

  • Final call after an interesting day of research is ARNA. I am certain based on the clues in the teaser pitch. I found t...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info